Gene Query: QPCT

Dataset Description Geneva Score
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 85.85
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 54.48
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 49.17
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 47.23
CD86 regulates a pro-survival signal in myeloma cells 43.34
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 35.77
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 35.61
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 34.42
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 33.65
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 33.28
ARID1A regulates condensin II distribution and chromosomal partition 33.28
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 32.36
HNF1 regulates critical functions of the human epididymis epithelium. 32.36
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 32.31
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 31.48
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 31.46
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 31.12
Identifying the molecular mode of action of itraconazole in colorectal cancer 29.48
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 29.31
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 27.72
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 27.68
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 25.68
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 25.36
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 25.3
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 22.91
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 22.09
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 22.09
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 21.61
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 20.36
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 20.23
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 20.23
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 20.15
Dysregulated immune system networks in war veterans with PTSD 18.58
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 18.57
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 18.57
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 18.57
Region-specific Innate Antiviral Responses of the Human Epididymis 18.2
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 17.82
RNA-seq of cancer cell lines treated with T-025 16.84
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 16.75
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 16.29
Gene expression profile of multiple myeloma cell lines treated with CB-5083 16.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 16.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 16.17
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 15.96
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 15.96
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 15.96
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 15.8
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 15.77
miR941 overexpression experiment 15.77
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 15.73
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 15.24
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 15.24
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 15.04
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 14.59
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 14.31
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 14.28
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 14.0
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.72
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.72
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 13.71
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 13.57
Identification of Nrf2 regulated genes by RNA sequencing 13.4
Nrf2 regulated genes in A549 cells 13.4
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 13.39
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 13.28
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 13.28
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 13.18
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 12.93
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 12.9
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 12.9
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 12.87
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 12.87
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 12.62
RNA-Seq in neutrophils from Antiphospholipid Syndrome 12.62
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 12.47
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 12.21
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 12.05
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 11.77
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 11.76
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 11.74
Gene expression changes in human melanoma cell lines compared to primary melanocytes 11.7
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 11.63
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 11.57
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 11.46
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.45
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 11.37
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 11.1
Effect of PRDM11 depletion in U2932 cells 10.96
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 10.9
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 10.53
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 10.53
Effect of disulfiram treatment on pediatric high grade glioma 10.44
TGF-β promotes genomic instability after loss of RUNX3 10.42
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 10.32
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 10.17
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 9.93
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 9.79
Macrophage Ad5f35 M2 Challenge 9.63
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 9.57
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 9.51
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.44
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.44
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 9.25
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 9.24
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.21
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 9.07
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 8.91
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 8.85
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 8.76
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 8.76
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.72
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 8.67
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.63
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 8.5
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 8.48
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 8.42
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 8.39
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.33
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 8.17
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 8.13
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 8.0
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 7.96
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 7.93
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 7.86
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 7.86
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.82
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 7.79
Gene expression profile in breast cancer cell lines using RNA sequencing 7.77
Non-coding regions are the main source of tumor-specific antigens [human] 7.72
Non-coding regions are the main source of tumor-specific antigens 7.72
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 7.59
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 7.54
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.54
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 7.52
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.5
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.5
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 7.48
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.37
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 7.27
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 7.14
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.13
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.13
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 7.12
NAPRT activation of macrophages 7.09
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 6.96
CHCHD2 gene KO effect in iPSC drived motor neurons 6.96
Expression data from miR340 overexpressing human A549 cells 6.91
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.89
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.89
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.87
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 6.86
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 6.82
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.77
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 6.75
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 6.72
Persistence of stem cell metabolism in cancers as a failure of differentiation 6.71
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 6.63
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 6.61
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 6.61
CHD1 regulates cell fate determination by activation of differentiation-induced genes 6.59
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 6.55
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 6.46
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.4
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 6.39
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.3
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.27
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.27
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 6.19
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 6.13
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.1
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.09
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 6.07
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 6.03
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 5.98
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.97
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 5.93
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 5.91
Transcriptional changes in lymphoma cells induced by LSD1 depletion 5.84
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 5.84
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 5.81
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 5.76
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 5.76
p63 controls the enhancer landscape during keratinocyte differentiation 5.75
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.75
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 5.74
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 5.71
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 5.71
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 5.66
RNA-seq analysis of BAP1-depleted uveal melanoma cells 5.63
Epigenetic reprogramming of melanoma cells by vitamin C treatment 5.63
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.61
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 5.59
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 5.59
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.58
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.51
Rorc disruption in human FG pancreatic cancer cells 5.51
RNA sequencing analysis of selumetinib-resistant CRC cells lines 5.47
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.47
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.47
Reassessment of Exosome Composition 5.47
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 5.47
Gene expression analysis of immortalized human liver progenitor-like cells in culture 5.42
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 5.39
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.39
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.39
High-Throughput Kinetic Analysis of Fractional Killing 5.35
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.34
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.34
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.24
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.23
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.22
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.21
CHCHD10 gene KO effect in iPSC drived motor neurons 5.18
Ribosomal protein RPL26 is the principal target of UFMylation 5.13
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.13
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 5.12
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.12
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 5.12
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 5.12
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 5.12
Trascriptome of thyroid cancer-induced macrophages 5.08
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.06
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.06
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 5.03
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 5.0
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 4.93
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 4.92
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.91
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.89
Random mono-allelic expression in MECP2-mutated cells 4.85
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.84
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.78
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.75
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 4.74
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.7
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.65
Patient-derived xenograft platform for metastatic melanoma 4.63
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 4.62
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 4.62
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 4.61
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 4.58
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 4.54
Transcriptome analysis of virus infected tissues 4.52
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.51
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.48
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.48
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.47
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 4.44
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 4.44
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 4.4
Transcriptional effect of ETV1 knockdown in melanoma cells 4.39
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.38
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.35
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.35
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.34
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.34
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.34
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 4.33
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.31
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.3
Gene expression profiling of papillary thyroid cancer from central and invasive regions 4.29
Global analysis of alternative splicing regulated by RBM10 4.25
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.2
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 4.19
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 4.19
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.15
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.14
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.09
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.09
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 4.07
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 4.06
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 4.06
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.03
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.01
The DNA methylation landscape of human melanoma [RNA-Seq] 4.01
The DNA methylation landscape of human melanoma 4.01
Human islets of varying quality: the good, the (not so) bad and the ugly 4.01
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 4.01
Irf9 function in immunity in mouse 4.01
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.99
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 3.98
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.94
Gene expression profiling in metabolically heterogeneous human lung tumors 3.92
MRTF activates TEAD-YAP target gene expression 3.91
Role of CD133 molecule in WNT response and renal repair 3.89
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.85
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.84
Transcriptome analyses of human pancreatic islets and pseudoislets 3.83
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.75
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 3.69
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.68
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.68
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 3.67
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.66
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.65
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.64
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 3.64
Molecular analysis of renal cell carcinoma with unclassfied histology 3.64
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.6
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.59
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.58
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.57
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 3.56
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 3.55
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.55
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 3.48
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 3.42
Transcriptional profile in human S. haematobium infection 3.4
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.36
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.34
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.33
Macrophage Ad5f35 PhenoMap 3.33
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 3.29
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 3.27
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 3.27
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 3.26
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.25
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 3.22
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.15
Total RNA sequencing of APC mutant and wt colonic organoids 3.14
Transcriptome wide analysis of classically and alternatively activated macrophages 3.14
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.13
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.08
Gene expression profile difference among renal location in a stone former 3.02
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 3.0
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 3.0
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 2.98
RNA-Seq and expression data from human adipose tissue 2.97
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.97
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 2.96
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.92
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 2.91
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.9
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 2.86
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 2.85
Anti-inflammatory effect of indoleacrylic acid (IA) 2.83
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.81
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.79
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.75
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.75
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.7
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 2.58
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.57
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 2.46
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 2.46
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 2.46
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.46
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.46
Transcriptome analysis of peripheral blood monocytes 2.43
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 2.41
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.41
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.39
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.37
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.37
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 2.37
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 2.35
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 2.33
Characterization of human ILC2 subsets 2.3
Determining mRNA half-lives on a transcriptome-wide scale 2.27
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.24
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.23
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.15
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.15
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.14
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.14
RNA-seq data 2.14
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.11
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 2.09
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 2.09
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.05
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.05
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.04
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.03
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.02
Expression analysis of the TAF1 syndrome 2.01
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.01
RNA seq_PDX2_SHP099 1.99
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.98
RNA-seq of primary patient AML samples 1.97
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 1.92
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.85
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.81
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.79
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.78
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.78
An optimization system for isolating and sequencing of single human colon cancer cells 1.78
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.77
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.76
RNA seq analysis of human Fetal and adult derived Enterospheres 1.63
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 1.61
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 1.6
Transcriptional responses of melanoma cells to BRAF inhibition 1.59
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.57
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.56
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.55
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.55
Gene expression analysis of human adenomas. 1.54
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.54
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.5
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.48
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.46
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.4
Tpl-2 small molecule project 1.4
Tpl-2 and MEK small molecule inhibitors 1.4
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.36
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.35
quanTIseq: quantifying immune contexture of human tumors 1.34
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.32
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.32
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.32
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.3
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.28
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.25
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.25
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 1.25
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.25
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.24
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.21
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.19
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.19
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.17
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.15
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.13
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.09
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.06
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.04
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.02
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.02
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.99
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 0.97
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 0.97
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.97
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.93
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.92
iPSC-Derived Cholangiocytes 0.9
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 0.9
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.85
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.83
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.81
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.81
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.8
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.76
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.76
Generation and functional characterization of MDSC-like cells 0.75
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.75
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.75
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.74
BMS-470539 on human synovial fibroblasts 0.72
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.7
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.7
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.69
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.64
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.63
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.61
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.61
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.6
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.59
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.53
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.5
Reprogrammed myeloid cell transcriptomes in NSCLC 0.5
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.42
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 0.41
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.4
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.4
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.4
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.38
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.34
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.33
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.3
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.3
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 0.3
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.3
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.3
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.29
The role of CFTR in islet function 0.27
The role of the Calcium-Sensing receptor in colorectal cancer 0.27
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 0.25
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.25
Gene expression of thyroid cancer cell lines 0.24
Transcriptomic analysis of human macrophages in 3D 0.24
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 0.2
Effects of rFVIIIFc on human macrophages 0.19
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.19
Specific molecular signatures underlie response to decitabine in CMML 0.18
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.18
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.15
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.14
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.13
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.12
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.07
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.05
Epigenomic conservation of transposable element silencing [RNA-seq] 0.04
Epigenomic conservation of transposable element silencing 0.04
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.04
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.04
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 0.02
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation